CHA AI Healthkare Files Corporate Governance Report: Multiple Deficiencies, 40 Billion Won Convertible Bond Issuance
CHA AI Healthkare disclosed its corporate governance report. Consolidated revenue dropped sharply to 7.3B KRW (from 15.7B), operating loss of 7.5B KRW, but net income turned positive at 1.4B KRW (vs. loss of 9.8B prior year).
The company failed to comply with many core governance indicators: no convocation notice 4 weeks before AGM, no electronic voting, no dividend policy, no CEO succession plan, all-male board, and lack of internal control/compliance policies.
The company plans to improve by introducing electronic voting, providing dividend predictability, establishing CEO succession policy, enacting risk management and compliance regulations, and increasing board diversity.
In October 2025, it issued 40B KRW in unsecured private convertible bonds (0% coupon, 1% yield, conversion price 8,292 KRW). The conversion price is above the current price (7,600 KRW), limiting short-term dilution risk, but significant dilution could occur if the stock price rises.
Major shareholder (MetaX1 Fund and one other) holds 77.7% stake. During the period, rights issues of 10B and 30B KRW were conducted to the major shareholder. No dividends were paid, and no shareholder return policy exists.
The auditor is a non-executive certified public accountant; no audit committee or internal audit support organization exists.
[AI Comprehensive Analysis]This routine governance disclosure reveals overall weak governance but a clear commitment to improvement. The convertible bond issuance poses limited dilution risk as the conversion price is above market, but the size (40B KRW) relative to market cap (138.4B KRW) could lead to substantial dilution if conversion occurs. Near-term, stable control and clear funding purpose mitigate material downside for shareholder value.